US2013085264A1PendingUtilityA1
Methods and Reagents for Diagnosing Hantavirus Infection
Assignee: NOVARTIS VACCINES & DIAGNOSTICPriority: Jun 18, 2004Filed: Dec 5, 2012Published: Apr 4, 2013
Est. expiryJun 18, 2024(expired)· nominal 20-yr term from priority
C07K 14/175C07K 16/10C07K 14/005C12N 2760/12122G01N 33/56983G01N 33/53G01N 33/569C12Q 1/70G01N 33/68
53
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Novel methods and immunodiagnostic test kits for the detection of hantavirus infection are disclosed. The methods and kits employ combinations of recombinant N and/or G1 antigens from at least six different hantavirus serotypes, including Hantann (HTNV), Puumala (PUUV), Seoul (SEOV), Dobrava (DOBV), Sin Nombre (SNV) and Andes (ANDV). Additional hantavirus antigens from these and other hantavirus types may also be present. The methods provide for highly accurate results and allow the detection of infection so that treatment can be administered and death avoided.
Claims
exact text as granted — not AI-modified1 . A hantavirus recombinant N antigen, said N antigen comprising an amino acid sequence selected from the group consisting of SEQ ID NO:28, SEQ ID NO:32, SEQ ID NO:34.
2 . The N antigen of claim 1 , wherein said N antigen comprises an amino acid sequence with at least about 75% identity to a sequence selected from the group consisting of SEQ ID NO:49, SEQ ID NO:51, and SEQ ID NO:52.
3 . A hantavirus recombinant N antigen, said N antigen comprising an amino acid sequence with at least about 75% identity to a sequence selected from the group consisting of SEQ ID NO:48, SEQ ID NO:50, and SEQ ID NO:53.
4 . The N antigen of claim 2 or 3 , wherein said N antigen comprises an amino acid sequence with at least about 90% identity to a sequence selected from the group consisting of SEQ ID NO:49, SEQ ID NO:51, SEQ ID NO:52, SEQ ID NO:48, SEQ ID NO:50, and SEQ ID NO:53.
5 . The N antigen of claim 4 , wherein said N antigen comprises an amino acid sequence with at least about 95% identity to a sequence selected from the group consisting of SEQ ID NO:49, SEQ ID NO:51, SEQ ID NO:52, SEQ ID NO:48, SEQ ID NO:50, and SEQ ID NO:53.
6 . The N antigen of claim 5 , wherein said N antigen comprises an amino acid sequence with at least about 98% identity to a sequence selected from the group consisting of SEQ ID NO:49, SEQ ID NO:51, SEQ ID NO:52, SEQ ID NO:48, SEQ ID NO:50, and SEQ ID NO:53.
7 . The N antigen of claim 6 , wherein said N antigen comprises an amino acid sequence selected from the group consisting of SEQ ID NO:49, SEQ ID NO:51, SEQ ID NO:52, SEQ ID NO:48, SEQ ID NO:50, and SEQ ID NO:53.
8 . An immunodiagnostic test kit for detecting hantavirus infection, said test kit comprising the N antigen of claim 1 or 3 .Join the waitlist — get patent alerts
Track US2013085264A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.